Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Siegfried Holding AG ( (CH:SFZN) ) just unveiled an announcement.
Siegfried Holding AG announced a leadership change with Dr. Andreas Casutt stepping down as Chairman of the Board of Directors at the 2026 Annual General Meeting. Dr. Beat Walti, a current board member and experienced leader, is proposed as his successor. This transition is expected to continue Siegfried’s successful growth trajectory and strengthen its market position.
The most recent analyst rating on (CH:SFZN) stock is a Hold with a CHF92.00 price target. To see the full list of analyst forecasts on Siegfried Holding AG stock, see the CH:SFZN Stock Forecast page.
More about Siegfried Holding AG
The Siegfried Group is a global life sciences company with operations in Switzerland, Germany, Spain, France, Malta, the USA, and China. In 2024, it reported sales of CHF 1.295 billion and employed over 3,800 people across thirteen sites on three continents. Siegfried specializes in manufacturing pharmaceutical APIs and drug products, including tablets, capsules, sterile vials, ampoules, cartridges, and ointments, and offers development services. The company is publicly listed on the SIX Swiss Exchange.
Average Trading Volume: 62,498
Technical Sentiment Signal: Sell
Current Market Cap: CHF3.62B
For a thorough assessment of SFZN stock, go to TipRanks’ Stock Analysis page.